Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gwendolyn K Binder

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Nature Reviews. Drug Discovery|April 17, 2026
Realizing the promise of CAR-T cell therapies for autoimmune diseasesGwendolyn K Binder, Raphaël Ognar
Molecular Therapy. Methods & Clinical Development|March 8, 2024
The very stable lentiviral vectorGwendolyn K Binder, Chien-Chung Chen
Microbes and Infection|May 10, 2003
Immune-mediated clearance of virus from the central nervous systemGwendolyn K Binder, Diane E Griffin
Journal of Virology|June 15, 2004
Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistanceXiaobin Lu, Qiao Yu, Gwendolyn K Binder, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 5, 2009
Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cellsGary P Wang, Bruce L Levine, Gwendolyn K Binder, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2005
Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cellsStephen E Braun, Fay Eng Wong, Michelle Connole, et al.
Human Gene Therapy|February 11, 2005
Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vectorPeter Manilla, Tessio Rebello, Cathleen Afable, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2004
Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral loadLaurent M Humeau, Gwendolyn K Binder, Xiaobin Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2006
Gene transfer in humans using a conditionally replicating lentiviral vectorBruce L Levine, Laurent M Humeau, Jean Boyer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 23, 2009
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivoMichael C Milone, Jonathan D Fish, Carmine Carpenito, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Nature Reviews. Drug Discovery|April 17, 2026
Realizing the promise of CAR-T cell therapies for autoimmune diseasesGwendolyn K Binder, Raphaël Ognar
Molecular Therapy. Methods & Clinical Development|March 8, 2024
The very stable lentiviral vectorGwendolyn K Binder, Chien-Chung Chen
Microbes and Infection|May 10, 2003
Immune-mediated clearance of virus from the central nervous systemGwendolyn K Binder, Diane E Griffin
Journal of Virology|June 15, 2004
Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistanceXiaobin Lu, Qiao Yu, Gwendolyn K Binder, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 5, 2009
Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cellsGary P Wang, Bruce L Levine, Gwendolyn K Binder, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2005
Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cellsStephen E Braun, Fay Eng Wong, Michelle Connole, et al.
Human Gene Therapy|February 11, 2005
Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vectorPeter Manilla, Tessio Rebello, Cathleen Afable, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2004
Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral loadLaurent M Humeau, Gwendolyn K Binder, Xiaobin Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2006
Gene transfer in humans using a conditionally replicating lentiviral vectorBruce L Levine, Laurent M Humeau, Jean Boyer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 23, 2009
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivoMichael C Milone, Jonathan D Fish, Carmine Carpenito, et al.
Pageof 2